{"podcast":{"title":"Business Of Biotech","slug":"business-of-biotech-123501","podcast_index_feed_id":123501,"rss_url":"https://rss.buzzsprout.com/1011661.rss","website_url":"https://www.bioprocessonline.com/solution/the-business-of-biotech-podcast","image_url":"https://storage.buzzsprout.com/35u0bccu9j9xpr9zrrjias54otax?.jpg","author":"Ben Comer","episode_count":310,"summary":"The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.","last_synced_at":"2026-06-08T22:18:30.179389+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501"},"episode":{"title":"Transforming Chronic Kidney Disease With ProKidney's Bruce Culleton, M.D.","slug":"transforming-chronic-kidney-disease-with-prokidney-s-bruce-culleton-m-d","published_at":"2025-12-15T11:00:00+00:00","page_url":"https://stenobird.com/podcast/business-of-biotech-123501/transforming-chronic-kidney-disease-with-prokidney-s-bruce-culleton-m-d","show_page_url":"https://stenobird.com/podcast/business-of-biotech-123501","url":"https://www.buzzsprout.com/1011661/episodes/18342901-transforming-chronic-kidney-disease-with-prokidney-s-bruce-culleton-m-d.mp3","audio_url":"https://www.buzzsprout.com/1011661/episodes/18342901-transforming-chronic-kidney-disease-with-prokidney-s-bruce-culleton-m-d.mp3","summary":"We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Bruce Culleton, M.D., CEO at ProKidney, talks about moving from academic research to industry and the role a key mentor played in his career path. Bruce discusses his experiences as a first-time CEO at ProKidney, a late-stage autologous cell therapy biotech focused on pioneering new treatments for chronic kidney disease (CKD), the benefits of FDA's Regenerative Medicine Advanced Therapy ...","meta_description":"We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Bruce Culleton, M.D., CEO at ProKidney, talks ab…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3336,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/transforming-chronic-kidney-disease-with-prokidney-s-bruce-culleton-m-d/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/business-of-biotech-123501/transforming-chronic-kidney-disease-with-prokidney-s-bruce-culleton-m-d.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}